🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Learn about mild behavioral impairment in an interactive session involving a case presentation, short quiz, and live Q&A with experts, Dr. Zahinoor Ismail and Dr. Byron Creese. Join on May 8, 2025, 10AM CT. Register at alz-org.zoom.us/webinar/regist… ISTAART Neuropsychiatric Syndromes PIA.

In >9000 older adults across the UK and Sweden, Dr Jean Stafford et al. found that depressive symptoms partly mediated the association between social support and cognition over time. Read more in The Lancet Longevity: thelancet.com/journals/lanhl…

A new ISTAART Voices episode on the effect of stressful life events on dementia risk with Dr. Avinash Chandra just dropped! Listen to this and other episodes of the ISTAART Voices podcast at istaart.alz.org/podcasts or your favorite podcast app.

May is all about the ISTAART Clinical Case Reports Webinars! Check out and register for upcoming webinars (including our own) at istaart.alz.org/calendar. Programs will provide a detailed walk-through of a clinical case study, followed by a quiz, and Q&A.

Don't forget to register to #AAIC25 by May 16 for early bird registration! Featuring more than 4000 posters and over 800 podium presentations, join us at the most important Alzheimer’s and dementia research conference of the year! alz.org/AAIC

NPS outside of core bvFTD criteria are common across the disease course and show distinct patterns of clustering and fluctuation. Read about the recent findings by Morrow et al. in Psychiatry and Clinical Neurosciences: lhttps://onlinelibrary.wiley.com/doi/full/10.1111/pcn.13810

NPS outside of core bvFTD criteria are common across the disease course and show distinct patterns of clustering and fluctuation. Read about the recent findings by Morrow et al. here: lhttps://onlinelibrary.wiley.com/doi/full/10.1111/pcn.13810

NPS PIA Fun Fact: Neuropsychiatric symptoms can affect up to 97% of individuals with dementia during the disease course. Learn more about NPS by getting involved with NPS PIA activities!

NPS PIA Fun Fact Series #2: NPS can emerge even before cognitive decline is detectable — in the prodromal stages of neurodegenerative disease. When these changes are later life emergent and persistent, these NPS are referred to as mild behavioral impairment.

NPS PIA Fun Fact Series #3: Symptoms like apathy, depression, irritability, and agitation may not just “normal aging” — they may signal underlying neurodegenerative changes, just like certain changes in cognition.

We are extremely proud to see the new cohort of ISTAART Ambassadors! Special shout out to Daniella Vellone, who is also the Member-in-Training of the NPS PIA!

NPS PIA Fun Fact Series #4: Treating NPS isn’t only about symptom control. Early detection and intervention may delay institutionalization and improve quality of life for both patients and caregivers.

#AAIC25 is coming and the NPS PIA is sure to have a strong presence there! Check our social media over the next few months to hear all about Neuropsychiatric Syndromes PIA #AAIC25 activities!

Join us at the first NPS PIA #AAIC25 Intermissions at Metro Toronto Convention Centre Room 808 on Tuesday, July 29, 2025; 12:15 - 2:00 PM. Attend the Peripheral and Central Physiological Markers for the Detection and Monitoring of Neuropsychiatric Symptoms

Want to learn more about how to analyze NPS data at #AAIC25? Register for the Applied Regression Analysis in R pre-conference workshop on July 25, 2025, 8am-12pm featuring NPS specific examples!

Join us at the second NPS PIA AAIC25 Intermissions at Metro Toronto Convention Centre Room 808 on Wednesday, July 30, 2025; 12:15 - 2:00 PM. Attend the Neuropsychiatric Syndromes PIA and @AAGP - Meet, Mingle and Get Involved Intermissions session! #AAIC25

Systematic reviews are one of the best ways to collaborate with other ISTAART researchers. Learn vital skills at #AAIC25 by registering for the Systematic Reviews for Dementia Researchers: Tools, Techniques, and Best Practices pre-conference workshop on July 25, 1-5pm!

Otsuka is currently supporting Investigator Sponsored Studies (ISS) on the "Investigational use of Otsuka products for treatment of agitation associated with dementia due to Alzheimer’s disease". Learn more at otsuka.envisionpharma.com/ienv_otsuka/vi…

Dr. Oury Monchi et al. identified disrupted white matter connectivity between the left amygdala and putamen in PD patients with MBI, pointing to structural correlates of early behavioural symptoms. Read the full article here: doi.org/10.1002/mds.29…

Dr. Teruyuki Matsuoka et al. validated the Japanese version of the MBI Checklist (MBI-C) and explored how loneliness relates to MBI in cognitively normal individuals and those with mild cognitive impairment (MCI). Read the full article here: journals.sagepub.com/doi/full/10.32…